Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

Henry D, Stehlik P, Rosella L.

Int J Epidemiol. 2018 Apr 1;47(2):675-676. doi: 10.1093/ije/dyy051. No abstract available.

PMID:
29618002
2.

Authors' reply to commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

Brophy JM, Bally M.

Int J Epidemiol. 2018 Apr 1;47(2):674-675. doi: 10.1093/ije/dyy050. No abstract available.

PMID:
29596629
3.

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

Stehlik P, Rosella L, Henry D.

Int J Epidemiol. 2018 Apr 1;47(2):362-367. doi: 10.1093/ije/dyx284. No abstract available.

PMID:
29390133
4.

[Cardiovascular side effects of non-steroidal anti-inflammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous].

Horváth VJ, Tabák GÁ, Szabó G, Putz Z, Koós CG, Lakatos P.

Orv Hetil. 2015 Mar 29;156(13):516-20. doi: 10.1556/OH.2015.30120. Review. Hungarian.

PMID:
25796279
5.

[Non steroidal anti-inflammatory drugs (NSAIDs) - balancing gastrointestinal complications and the cardiovascular risk].

Kandulski A, Venerito M, Malfertheiner P.

Dtsch Med Wochenschr. 2009 Aug;134(33):1635-40; quiz 1641-4. doi: 10.1055/s-0029-1233993. Epub 2009 Jul 31. Review. German.

PMID:
19650027
6.

Non-steroidal anti-inflammatory drugs and cardiovascular risk--a rheumatologist's.

Whitelaw D.

S Afr Med J. 2007 Dec;97(12):1230. No abstract available.

PMID:
18264598
7.

Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?

Sfikakis PP, Bournia VK, Kitas G.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 87):S-8-9. Epub 2014 Oct 20. No abstract available.

PMID:
25327337
8.

Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.

Zingler G, Hermann B, Fischer T, Herdegen T.

Expert Rev Clin Pharmacol. 2016 Nov;9(11):1479-1492. doi: 10.1080/17512433.2016.1230495. Epub 2016 Sep 8. Review.

PMID:
27575590
9.

Non-steroidal anti-inflammatory drugs and cardiovascular risk.

Allwood B, Blockman M.

S Afr Med J. 2008 Jan;98(1):9-10. No abstract available.

PMID:
18270624
10.

Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.

Russell RI.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S14-8. Review.

PMID:
10379464
11.
12.

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.

Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P.

BMJ. 2011 Jan 11;342:c7086. doi: 10.1136/bmj.c7086. Review.

13.

Non-steroidal anti-inflammatory drugs and cardiovascular risk.

Chin A, Commerford P.

S Afr Med J. 2007 Jul;97(7):500-3. Review. No abstract available.

PMID:
17824137
14.

Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.

Woodruff T.

Intern Med J. 2006 Dec;36(12):797-8; author reply 798-9. No abstract available.

PMID:
17096747
15.

Cardiovascular hazard and non-steroidal anti-inflammatory drugs.

Wang D, Wang M, Cheng Y, Fitzgerald GA.

Curr Opin Pharmacol. 2005 Apr;5(2):204-10. Review. Erratum in: Curr Opin Pharmacol. 2005 Oct;5(5):556. Wong, Dairong [corrected to Wang, Dairong].

PMID:
15780832
16.

Ischaemic cardiovascular risk and prescription of non-steroidal anti-inflammatory drugs for musculoskeletal complaints.

Koffeman AR, Valkhoff VE, Jong GW, Warlé-van Herwaarden MF, Bindels PJ, Sturkenboom MC, Luijsterburg PA, Bierma-Zeinstra SM.

Scand J Prim Health Care. 2014 Jun;32(2):90-8. doi: 10.3109/02813432.2014.929810. Epub 2014 Jun 15.

17.

[Nonsteroidal anti-inflammatory drugs and the risk of cardiovascular diseases].

Jukić A, Kaliterna DM, Radić M.

Reumatizam. 2010;57(1):26-8. Review. Croatian.

PMID:
20941937
18.

Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.

Fosbøl EL, Køber L, Torp-Pedersen C, Gislason GH.

Expert Opin Drug Saf. 2010 Nov;9(6):893-903. doi: 10.1517/14740338.2010.501331. Review.

PMID:
20569079
19.

Hot Topics in Primary Care: Nonsteroidal Anti- inflammatory Drugs and Cardiovascular Risk: Where Are We Today?

Ruoff G.

J Fam Pract. 2015 Dec;64(12 Suppl):S67-70. Review. No abstract available.

PMID:
26845017

Supplemental Content

Support Center